Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05363800
What this trial is testing

Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

Who this might be right for
Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
Jiangsu HengRui Medicine Co., Ltd. 74
Testing effectiveness (Phase 2)WithdrawnNCT05471492
What this trial is testing

Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Telavant, Inc.
Not applicableStudy completedNCT03955900
What this trial is testing

A Registry Study of Participants With Multiple Myeloma in Latin America

Who this might be right for
Multiple Myeloma
Janssen-Cilag Ltd. 2,059
Not applicableUnknownNCT04070807
What this trial is testing

Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2

Who this might be right for
Acute Myeloid Leukemia
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 70
Testing effectiveness (Phase 2)Study completedNCT00004907
What this trial is testing

Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Early research (Phase 1)Ended earlyNCT01034592
What this trial is testing

Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia

Who this might be right for
AnemiaLeukemiaAcute Myeloid Leukemia (AML)+1 more
Jason Robert Gotlib 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05768711
What this trial is testing

Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)

Who this might be right for
Chronic Myeloid Leukemia
Groupe Francophone des Myelodysplasies 44
Not applicableLooking for participantsNCT07570407
What this trial is testing

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic HSCTPosttransplant ComplicationsGvHD+2 more
University Hospital Pilsen 75
Large-scale testing (Phase 3)Active Not RecruitingNCT06514807
What this trial is testing

Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

Who this might be right for
Essential Thrombocythaemia
AOP Orphan Pharmaceuticals AG 117
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Early research (Phase 1)Not Yet RecruitingNCT06500507
What this trial is testing

QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT00035607
What this trial is testing

Chemotherapy Related Anemia

Who this might be right for
AnemiaNon-Myeloid Malignancies
Amgen 120
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Not applicableStudy completedNCT05147311
What this trial is testing

Positive Psychology Intervention In HSCT

Who this might be right for
Hematologic MalignancyHematopoietic/Lymphoid CancerBlood Cancer
Brigham and Women's Hospital 72
Large-scale testing (Phase 3)UnknownNCT04083911
What this trial is testing

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

Who this might be right for
Acute Myeloid LeukemiaInduction Chemotherapy
The First Affiliated Hospital of Soochow University 50
Early research (Phase 1)Ended earlyNCT00100971
What this trial is testing

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Boston Medical Center 9
Early research (Phase 1)Study completedNCT01195311
What this trial is testing

A Dose-escalation Study in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 52
Early research (Phase 1)Study completedNCT03393611
What this trial is testing

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Relapsed Adult Acute Myeloid+1 more
Weill Medical College of Cornell University 14
Early research (Phase 1)Ended earlyNCT03103971
What this trial is testing

HuJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent Adult Acute Lymphoblastic LeukemiaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma+14 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)UnknownNCT00885508
What this trial is testing

The Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q

Who this might be right for
Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Groupe Francophone des Myelodysplasies 85
Next Page